Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-22-006321

Chief Development Officer sold 2,043 shares at an average $3.69 ($7,545)

From the SEC's structured data for this filing

Trades in this filing

LeBel Carl · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-18 Sale : show line 1 in the form −974 $3.87 $3,772 12,195 D
2022-02-22 Sale : show line 2 in the form −1,069 $3.53 $3,773 11,126 D
Open-market sales · 2,043 sh · avg $3.69 · $7,545
Loading xslF345X03/form4.xml…